**Aging Population and Increasing Prevalence of Sleep Apnea/Obesity**: The global market for sleep apnea devices is experiencing sustained growth, driven by demographic trends such as an aging population and rising rates of obesity, both of which significantly contribute to the prevalence of sleep apnea.

**Competitive Landscape and Supply Chain Dynamics**: The aftermath of the Philips Respironics product recall has created shifts in market share and supply chain pressures within the sleep apnea device industry. ResMed's ability to capitalize on this and manage its own supply chain to meet increased demand remains a key factor.

**Healthcare Regulations, Reimbursement Pressures, and Digital Health Integration**: The stock is affected by evolving healthcare regulations, particularly in the US, where reimbursement compression and labor inflation are influencing commercial strategies. Concurrently, there is a strong industry trend towards the adoption of digital health solutions, cloud-connected medical devices, and AI for enhanced patient monitoring and care efficiency.